Paper4147159
Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
Williams MN and 4 others. J Biol Chem, 1973. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli. Papers, record 4147159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4147159
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Methotrexate | Major topic |
| Tetrahydrofolate Dehydrogenase | Major topic |
| Binding Sites | |
| Chromatography, Affinity | |
| Chromatography, Gel | |
| Chromatography, Ion Exchange | |
| Drug Resistance, Microbial | |
| Folic Acid | |
| Folic Acid Antagonists | |
| Kinetics | |
| NADP | |
| Osmolar Concentration | |
| Oxidation-Reduction | |
| Protein Binding | |
| Spectrometry, Fluorescence | |
| Spectrophotometry, Ultraviolet | |
| Time Factors |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40125244 | Conversion of Chemical Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload Stoichiometry for Optimal Biodistribution in Cancer Treatment. | RNA Nanomed | 2024 | https://conductscience.org/library/papers/40125244 | PubMed |
| 36499436 | Methotrexate-Induced Liver Injury Is Associated with Oxidative Stress, Impaired Mitochondrial Respiration, and Endoplasmic Reticulum Stress In Vitro. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499436 | PubMed |
| 35056966 | Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/35056966 | PubMed |
| 24936211 | Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders. | J Cheminform | 2014 | https://conductscience.org/library/papers/24936211 | PubMed |
| 23798536 | Poison domains block transit of translocated substrates via the Legionella pneumophila Icm/Dot system. | Infect Immun | 2013 | https://conductscience.org/library/papers/23798536 | PubMed |
| 6761546 | Nucleotide sequence of dihydrofolate reductase genes from trimethoprim-resistant mutants of Escherichia coli. Evidence that dihydrofolate reductase interacts with another essential gene product. | Mol Gen Genet | 1982 | https://conductscience.org/library/papers/6761546 | PubMed |
| 4361998 | Similarity in the sequence of Escherichia coli dihydrofolate reductase with other pyridine nucleotide-requiring enzymes. | Nature | 1974 | https://conductscience.org/library/papers/4361998 | PubMed |
| 785230 | Regulatory mutants of dihydrofolate reductase in Escherichia coli K12. | Mol Gen Genet | 1976 | https://conductscience.org/library/papers/785230 | PubMed |
| 390304 | Regulation of dihydrofolate reductase synthesis in Escherichia coli. | Mol Gen Genet | 1979 | https://conductscience.org/library/papers/390304 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4147159
GET https://conductscience.org/api/papers/v1/4147159/authors